These studies investigated, respectively, TrKa expression and TrKa-dependent signaling in OSA cell lines and in primary tumors and their lung metastases [39], and the efficacy of bedinvetmab as a palliative treatment in primary bone tumors [54]. The gene discussed is NTRK1; the disease is obstructive sleep apnea syndrome.